Terms: = Liver cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Prognosis
18 results:
1. Nomograms confirm serum IL-6 and CRP as predictors of immune checkpoint inhibitor efficacy in unresectable hepatocellular carcinoma.
Du J; Huang Z; Zhang E
Front Immunol; 2024; 15():1329634. PubMed ID: 38304429
[TBL] [Abstract] [Full Text] [Related]
2. Integrated network findings reveal ubiquitin-specific protease 44 overexpression suppresses tumorigenicity of liver cancer.
Zhou H; Yang L; Lin X; Chan TF; Lee NP; Tse WKF; Zhang X; Li R; Lai KP
Aging (Albany NY); 2023 May; 15(10):4304-4318. PubMed ID: 37204480
[TBL] [Abstract] [Full Text] [Related]
3. Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators.
Yu X; Yang R; He Z; Zeng P
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8969-8979. PubMed ID: 37160627
[TBL] [Abstract] [Full Text] [Related]
4. The Deubiquitinating Enzyme USP4 Functions as an Oncoprotein in Gastric cancer and Mediates NF-κB Signaling by Regulating PRL-3 Expression.
Tao Y; You W
Front Biosci (Landmark Ed); 2022 Oct; 27(10):286. PubMed ID: 36336860
[TBL] [Abstract] [Full Text] [Related]
5. Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma.
Jang SY; Kim G; Tak WY; Kweon YO; Lee YR; Han YS; Han JR; Park JG; Kang MK; Lee HW; Lee WK; Park SY; Hur K
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011395
[TBL] [Abstract] [Full Text] [Related]
6. Influencing factors related to transcatheter arterial chemoembolization for hepatocellular carcinoma patients achieved tumor response.
Shao H; Deng J; Xie L; Zheng Q; Zou B; Deng J; Zhang T; He J
J Cancer Res Ther; 2022 Apr; 18(2):560-566. PubMed ID: 35645128
[TBL] [Abstract] [Full Text] [Related]
7. Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease.
Hagström H; Thiele M; Simon TG; Sharma R; Röckert Tjernberg A; Roelstraete B; Söderling J; Ludvigsson JF
United European Gastroenterol J; 2022 Mar; 10(2):198-211. PubMed ID: 35088575
[TBL] [Abstract] [Full Text] [Related]
8. Hypermethylation of Cyclin D2 Predicts Poor prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma after Hepatectomy.
Qian Y; Wang H; Zhang Y; Wang JW; Fan YC; Gao S; Wang K
Tohoku J Exp Med; 2021 Jul; 254(3):233-243. PubMed ID: 34334537
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Factors After Surgical Treatment of liver Metastases from Breast cancer - 19 Years of Experience.
ProchÁzkovÁ K; PivovarČÍkovÁ K; RouŠarovÁ M; VodiČka J; HoŠek P; TŘeŠkovÁ I; Hes O; KuČera R; TopolČan O; TŘeŠka V
In Vivo; 2021; 35(1):417-422. PubMed ID: 33402491
[TBL] [Abstract] [Full Text] [Related]
10. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
Cui K; Ou Y; Shen Y; Li S; Sun Z
Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399
[TBL] [Abstract] [Full Text] [Related]
11. Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Wang MD; Li C; Liang L; Xing H; Sun LY; Quan B; Wu H; Xu XF; Wu MC; Pawlik TM; Lau WY; Shen F; Yang T
Oncologist; 2020 Oct; 25(10):e1541-e1551. PubMed ID: 32472951
[TBL] [Abstract] [Full Text] [Related]
12. Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
Hiraoka A; Kumada T; Tada T; Fukunishi S; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Kariyama K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Kawata K; Toyoda H; Ohama H; Tsutsui A; Itokawa N; Hayama K; Arai T; Imai M; Nakamura S; Michitaka K; Hiasa Y; Kudo M;
Oncology; 2020; 98(5):295-302. PubMed ID: 32097925
[TBL] [Abstract] [Full Text] [Related]
13. Serum Exosomal Long Noncoding RNAs
Xu H; Chen Y; Dong X; Wang X
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):710-716. PubMed ID: 29650788
[No Abstract] [Full Text] [Related]
14. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
Arbelaiz A; Azkargorta M; Krawczyk M; Santos-Laso A; Lapitz A; Perugorria MJ; Erice O; Gonzalez E; Jimenez-Agüero R; Lacasta A; Ibarra C; Sanchez-Campos A; Jimeno JP; Lammert F; Milkiewicz P; Marzioni M; Macias RIR; Marin JJG; Patel T; Gores GJ; Martinez I; Elortza F; Falcon-Perez JM; Bujanda L; Banales JM
Hepatology; 2017 Oct; 66(4):1125-1143. PubMed ID: 28555885
[TBL] [Abstract] [Full Text] [Related]
15. Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
Fan JL; Yang YF; Yuan CH; Chen H; Wang FB
Cell Physiol Biochem; 2015; 37(2):629-40. PubMed ID: 26344495
[TBL] [Abstract] [Full Text] [Related]
16. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score.
Chan AW; Chan RC; Wong GL; Wong VW; Choi PC; Chan HL; To KF
J Gastroenterol Hepatol; 2015 Sep; 30(9):1391-6. PubMed ID: 25753927
[TBL] [Abstract] [Full Text] [Related]
17. A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients.
Kim SK; Kim SY; Kim JH; Roh SA; Cho DH; Kim YS; Kim JC
Mol Oncol; 2014 Dec; 8(8):1653-66. PubMed ID: 25049118
[TBL] [Abstract] [Full Text] [Related]
18. Methylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinoma.
Tsutsui M; Iizuka N; Moribe T; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Fujita Y; Hamamoto Y; Tsunedomi R; Iida M; Tokuhisa Y; Sakamoto K; Tamesa T; Sakaida I; Oka M
Clin Chim Acta; 2010 Apr; 411(7-8):516-20. PubMed ID: 20064498
[TBL] [Abstract] [Full Text] [Related]
